We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$42.4B
1-Year Est. Return
181.11%
This Fund
S&P 500
This Quarter
Est. Return
-0.56%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$15.7B
AUM Growth
-$1.33B
(-7.8%)
Cap. Flow
-$153M
Cap. Flow
% of AUM
-0.98%
Top 10 Holdings %
Top 10 Hldgs %
39.89%
Holding
471
New
38
Increased
139
Reduced
173
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$70.7M |
| 2 |
Meta Platforms (Facebook)
META
|
+$66.5M |
| 3 |
Becton Dickinson
BDX
|
+$61.6M |
| 4 |
GitLab
GTLB
|
+$58.7M |
| 5 |
Teradyne
TER
|
+$58.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$85.2M |
| 2 |
Steris
STE
|
+$78.2M |
| 3 |
CVS Health
CVS
|
+$62.9M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$61.9M |
| 5 |
FIVE9
FIVN
|
+$58.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.08% |
| 2 | Industrials | 22.24% |
| 3 | Healthcare | 19.2% |
| 4 | Financials | 15.72% |
| 5 | Communication Services | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Toronto Dominion Bank
TD
$198B
| $16.8M | 0.11% |
221,791
-92,774
| -29% | -$6.01M |
|
152
HCA Healthcare
HCA
$92.4B
| $16.2M | 0.1% |
+88,000
| New | +$17.5M |
|
|
AKYA
153
DELISTED
Akoya BioSciences
AKYA
| $15.5M | 0.1% |
1,315,470
| – | – |
|
154
Sea Limited
SE
$66.6B
| $15.4M | 0.1% |
274,784
-32,282
| -11% | -$2.25M |
|
155
Cannae Holdings
CNNE
$679M
| $15.3M | 0.1% |
739,966
+64,691
| +10% | +$1.39M |
|
156
Netflix
NFLX
$334B
| $14.7M | 0.09% |
624,860
-4,370
| -0.7% | -$97.1K |
|
|
CERE
157
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $14.6M | 0.09% |
518,276
+18,276
| +4% | +$544K |
|
158
Affiliated Managers Group
AMG
$9.2B
| $14.4M | 0.09% |
129,126
-24,693
| -16% | -$3.1M |
|
|
AVDL
159
DELISTED
Avadel Pharmaceuticals
AVDL
| $14.1M | 0.09% |
2,812,490
| – | – |
|
|
AXON
160
Axon Enterprise
AXON
$39.8B
| $13.8M | 0.09% |
119,359
-17,951
| -13% | -$2.03M |
|
161
Uber
UBER
$148B
| $13.6M | 0.09% |
511,972
+115,187
| +29% | +$3.18M |
|
162
PNC Financial Services
PNC
$97.4B
| $13.2M | 0.08% |
88,113
-12,653
| -13% | -$2.05M |
|
163
Surgery Partners
SGRY
$1.84B
| $12.9M | 0.08% |
553,018
+57,323
| +12% | +$1.83M |
|
164
Paycom
PAYC
$9.87B
| $12.9M | 0.08% |
39,145
-41,840
| -52% | -$14.4M |
|
165
Union Pacific
UNP
$169B
| $12.8M | 0.08% |
65,886
+1,555
| +2% | +$344K |
|
166
Norfolk Southern
NSC
$71.9B
| $12.5M | 0.08% |
59,829
+1,412
| +2% | +$340K |
|
167
Emerson Electric
EMR
$84.9B
| $12.1M | 0.08% |
165,812
| – | – |
|
168
Icon
ICLR
$13B
| $11.8M | 0.08% |
64,078
+16,042
| +33% | +$3.49M |
|
169
Qiagen
QGEN
$8.65B
| $11.8M | 0.07% |
207,722
+163,849
| +373% | +$8.09M |
|
170
Tenet Healthcare
THC
$21.2B
| $11.2M | 0.07% |
216,582
-193,988
| -47% | -$11.5M |
|
171
Datadog
DDOG
$82.6B
| $10.8M | 0.07% |
+121,232
| New | +$12.2M |
|
|
RCM
172
DELISTED
R1 RCM Inc. Common Stock
RCM
| $10.8M | 0.07% |
580,220
+30,379
| +6% | +$693K |
|
|
PPLI
173
People Inc
PPLI
$2.9B
| $10.5M | 0.07% |
231,687
-1,621
| -0.7% | -$91.3K |
|
|
XYZ
174
Block Inc
XYZ
$47.8B
| $10.5M | 0.07% |
190,817
+29,229
| +18% | +$2.07M |
|
175
Spotify
SPOT
$114B
| $10.4M | 0.07% |
120,774
+21,503
| +22% | +$2.3M |
|
Similar funds
GAM
SAM
Polar Capital Holdings's Q3 2022 Portfolio in Review
As of Q3 2022, Polar Capital Holdings held 471 positions worth $15.7B, down 7.8% from $17B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Polar Capital Holdings's Q3 2022 filing shows 38 new, 139 increased, 173 reduced and 54 closed positions. Its largest new stake was DexCom: 834,956 shares worth $67.2M. The largest sale was Adobe, an estimated $85.2M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Industrials and Healthcare.
- Polar Capital Holdings's largest Q3 2022 buy was DexCom: 834,956 shares worth $67.2M.
- Polar Capital Holdings added most to Meta Platforms (Facebook) in Q3 2022, an estimated $66.5M increase.
- Polar Capital Holdings's biggest Q3 2022 reduction was Neurocrine Biosciences, cutting an estimated $61.9M.
- Polar Capital Holdings fully exited Adobe in Q3 2022, selling an estimated $85.2M.
- Polar Capital Holdings's ten largest holdings make up 40% of its $15.7B portfolio in Q3 2022.
- Polar Capital Holdings opened 38 new positions and closed 54 in Q3 2022.
- Polar Capital Holdings's portfolio value fell 7.8% quarter-over-quarter to $15.7B.
Based on Polar Capital Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.